Trials / Unknown
UnknownNCT02418247
Minimize Radioactive Iodine Ablation Of Remnant Thyroid in Differentiated Thyroid Cancer
Phase Ⅱ Non-randomized Multicenter Controlled Trial About Effect of Remnant Ablation Therapy on the Recurrence in Low-risk Differentiated Thyroid Cancer Patients
- Status
- Unknown
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 556 (estimated)
- Sponsor
- National Cancer Center, Korea · Other Government
- Sex
- All
- Age
- 18 Years – 79 Years
- Healthy volunteers
- Not accepted
Summary
The researchers investigated the rate of biochemical remission in patients without radioactive iodine therapy compared to patients with low dose radioactive iodine treatment in differentiated thyroid cancer patients who underwent total thyroidectomy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | I131 | |
| DRUG | I123 |
Timeline
- Start date
- 2013-05-01
- Primary completion
- 2017-12-01
- Completion
- 2020-12-01
- First posted
- 2015-04-16
- Last updated
- 2017-01-20
Locations
5 sites across 1 country: South Korea
Source: ClinicalTrials.gov record NCT02418247. Inclusion in this directory is not an endorsement.